FDA Approved: ENTECAVIR — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approves a supplemental application for AvKARE to market entecavir, expanding the generic supply of the antiviral for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)